Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 3061 AL 3075

[Overuse of antidepressant in older outpatients with Alzheimer disease and associated disorders: an observational study]

Gourdon M, Petit L, Delpierre S, Sebbagh-Eczet M, Estrada J, Marquis C, Raynaud-Simon A, Bonnet-Zamponi D.

Geriatr Psychol Neuropsychiatr Vieil. 2020 Dec 1;18(4):395-404. doi: 10.1684/pnv.2020.0850.

Modulation of Brain Hyperexcitability: Potential New Therapeutic Approaches in Alzheimer's Disease

Toniolo S, Sen A, Husain M.

Int J Mol Sci. 2020 Dec 7;21(23):9318. doi: 10.3390/ijms21239318.

Role of reactive oxygen species in the progression of Alzheimer's disease

Bhatt S, Puli L, Patil CR.

Drug Discov Today. 2021 Mar;26(3):794-803. doi: 10.1016/j.drudis.2020.12.004. Epub 2020 Dec 8.

AMPK: A bridge between diabetes mellitus and Alzheimer's disease

Chen M, Huang N, Liu J, Huang J, Shi J, Jin F.

Behav Brain Res. 2021 Feb 26;400:113043. doi: 10.1016/j.bbr.2020.113043. Epub 2020 Dec 8.

Galantamine beyond Alzheimer's disease-a fact or artefact?

Naguy A, Husain K, Alamiri B.

CNS Spectr. 2022 Jun;27(3):268-271. doi: 10.1017/S1092852920002229. Epub 2020 Dec 14.

Does a hypoxic injury from a non-fatal overdose lead to an Alzheimer Disease?

Voronkov M, Cocchiaro B, Stock JB.

Neurochem Int. 2021 Feb;143:104936. doi: 10.1016/j.neuint.2020.104936. Epub 2020 Dec 10.

Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?

Leng F, Edison P.

Nat Rev Neurol. 2021 Mar;17(3):157-172. doi: 10.1038/s41582-020-00435-y. Epub 2020 Dec 14.

Lessons Learnt from the Second Generation of Anti-Amyloid Monoclonal Antibodies Clinical Trials

Tian Hui Kwan A, Arfaie S, Therriault J, Rosa-Neto P, Gauthier S.

Dement Geriatr Cogn Disord. 2020;49(4):334-348. doi: 10.1159/000511506. Epub 2020 Dec 15.

GSK3α: An Important Paralog in Neurodegenerative Disorders and Cancer

Silva-García O, Cortés-Vieyra R, Mendoza-Ambrosio FN, Ramírez-Galicia G, Baizabal-Aguirre VM.

Biomolecules. 2020 Dec 16;10(12):1683. doi: 10.3390/biom10121683.

Therapeutic Targeting Strategies for Early- to Late-Staged Alzheimer's Disease

Kang YJ, Diep YN, Tran M, Cho H.

Int J Mol Sci. 2020 Dec 16;21(24):9591. doi: 10.3390/ijms21249591.

Protection against Alzheimer's disease by luteolin: Role of brain glucose regulation, anti-inflammatory activity, and the gut microbiota-liver-brain axis

Daily JW, Kang S, Park S.

Biofactors. 2021 Mar;47(2):218-231. doi: 10.1002/biof.1703. Epub 2020 Dec 21.

Recent Advances in Virtual Screening for Cholinesterase Inhibitors

Miles JA, Ross BP.

ACS Chem Neurosci. 2021 Jan 6;12(1):30-41. doi: 10.1021/acschemneuro.0c00627. Epub 2020 Dec 22.

c-Jun N-Terminal Kinase Inhibitors as Potential Leads for New Therapeutics for Alzheimer's Diseases

Hepp Rehfeldt SC, Majolo F, Goettert MI, Laufer S.

Int J Mol Sci. 2020 Dec 18;21(24):9677. doi: 10.3390/ijms21249677.

Nutraceutical Approaches of Autophagy and Neuroinflammation in Alzheimer's Disease: A Systematic Review

Gruendler R, Hippe B, Sendula Jengic V, Peterlin B, Haslberger AG.

Molecules. 2020 Dec 18;25(24):6018. doi: 10.3390/molecules25246018.

Is There Justification to Treat Neurodegenerative Disorders by Repurposing Drugs? The Case of Alzheimer's Disease, Lithium, and Autophagy

Damri O, Shemesh N, Agam G.

Int J Mol Sci. 2020 Dec 27;22(1):189. doi: 10.3390/ijms22010189.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias